Pierce David A, SVP and President, Endoscopy of Boston Scientific Corporation (NYSE:BSX), unloaded 18,612 shares at an average price of $14.31 on January 8, 2015. The total amount of the transaction was worth $266,338, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing. Pierce David A now owns 33,161 shares of Boston Scientific Inc. On Friday shares of Boston Scientific Corporation (NYSE:BSX) closed at $14.46. Company’s sales growth for last 5 years was -2.40% and EPS growth for next 5 years is recorded as 10.70%.

Novavax, Inc. (NASDAQ:NVAX) declared that Jill Hoyt has been nominated as VP of Human Resources & Administration. Ms. Hoyt moved into the firm in February 2008 as Executive Director, Human Resources & Administration and has been contributed in the effective growth of the firm. Novavax, Inc. (NASDAQ:NVAX) in last trading activity advanced 9.84% to close at $6.81. Company weekly performance is 7.92% while its quarterly performance stands at 31.72%. Novavax, Inc. (NASDAQ:NVAX) is -2.01% away from its 52 week high.

Colfax Corp (NYSE:CFX) CEO Clay Kiefaber sold 9,208 shares of the stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $47.54, for a total transaction of $437,748.32. Following the completion of the transaction, the chief executive officer now directly owns 108,823 shares of the company’s stock, valued at approximately $5,173,445.42. On last trading day Colfax Corporation (NYSE:CFX) decreased -0.27% to close at $44.72. Its volatility for the week is 3.91% while volatility for the month is 2.88%. CFX’s sales growth for past 5 years was 47.40% and its EPS growth for past 5 years was 85.10%. Colfax Corporation (NYSE:CFX) monthly performance is -6.46%.

Johnson & Johnson (NYSE: JNJ) announced the formation of consortia with leading global research institutions and non-government organizations to work in conjunction with Janssen Pharmaceutical Companies to accelerate the development of its Ebola vaccine regimen. The Innovative Medicines Initiative (IMI) plans to award these consortia grants totaling more than €100 million from the Ebola+ programme to support the development, manufacturing and patient education for the vaccine regimen. On Friday shares of Johnson & Johnson (NYSE:JNJ) closed at $104.04. Company’s sales growth for last 5 years was 2.30% and EPS growth for next 5 years is recorded as 6.17%.

First Busey Corporation (“Busey”) (NASDAQ:BUSE), the holding company for Busey Bank, on 9 January 2015 announced the completion of its previously announced acquisition of Herget Financial Corp. (“Herget Financial”), the holding company for Herget Bank, National Association (“Herget”). Under the terms of the definitive agreement, First Busey acquired 100% of Herget Financial’s outstanding common stock for aggregate cash consideration of $34.1 million. Busey will operate Herget as a separate banking subsidiary of Busey until it is merged with Busey Bank, which is expected to occur in the late first quarter of 2015. On last trading day First Busey Corporation (NASDAQ:BUSE) advanced 2.96% to close at $6.27. Its volatility for the week is 3.33% while volatility for the month is 2.76%. BUSE’s sales growth for past 5 years was -13.20% and its EPS growth for past 5 years was 17.90%. First Busey Corporation (NASDAQ:BUSE) monthly performance is -2.18%.